You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 2, February 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Naloxone

Underdosage After Narcotic Poisoning

Roger A. Moore, MD; Barry H. Rumack, MD; Christopher S. Conner, Pharm D; Robert G. Peterson, MD, PhD

Am J Dis Child. 1980;134(2):156-158.


Abstract

• A case of propoxyphene hydrochloride (Darvon) poisoning was unresponsive to therapeutic doses of naloxone hydrochloride in a 21/2-year-old girl. Following prolonged coma and artificial ventilation for three hours, the patient responded immediately to the intravenous administration of 2 mg of naloxone hydrochloride, which is 20 times the manufacturer's recommended dosage. Naloxone is the agent of choice in reversing the effects of narcotics and synthetic opiate derivatives, such as propoxyphene and pentazocine. The manufacturer's present recommended dosage may not be sufficient to reverse the effects of large narcotic ingestions. We therefore recommend that if there is no response within two minutes of the initial 0.01 mg/kg dosage of naloxone hydrochloride, a second dose 0.1 mg/kg (ten times the manufacturer's suggested dose) be given.

(Am J Dis Child 134:156-158, 1980)



Author Affiliations

From the Departments of Pediatrics (Drs Moore, Rumack, and Peterson), Medicine (Drs Rumack and Conner), Pharmacology (Dr Rumack), Clinical Pharmacy (Dr Conner), and Anesthesiology (Dr Peterson), and the Division of Clinical Pharmacology (Dr Rumack), University of Colorado Medical Center and Schools of Medicine and Pharmacy, Denver; the Rocky Mountain Poison Center, Denver General Hospital (Dr Rumack); and the Rocky Mountain Drug Consultation Center, Denver General Hospital (Dr Conner).


Footnotes

Reprint requests to Division of Clinical Pharmacology, Box C-237, University of Colorado Medical Center, 4200 E Ninth Ave, Denver, CO 80262 (Dr Rumack).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Naloxone in opioid poisoning: walking the tightrope
Clarke et al.
Emerg. Med. J. 2005;22:612-616.
ABSTRACT | FULL TEXT  

Clinical Features and Management of Distalgesic Overdose
Proudfoot
Hum Exp Toxicol 1984;3:85s-94S.
ABSTRACT  

Efficacy of Naloxone in Clonidine Poisoning
NORTH and PETERSON
Arch Pediatr Adolesc Med 1983;137:807-808.
ABSTRACT  

An Investigation of the Role of the Specific Opioid Antagonist Naloxone in Clinical Toxicology
Jefferys and Volans
Hum Exp Toxicol 1983;2:227-231.
ABSTRACT  

Possible Dangers of Naloxone Use-Reply
Kulig et al.
JAMA 1982;248:2973-2973.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.